The rapid spread of ovarian cancer to distant organs within the abdomen contributes to its morbidity and mortality in affected women. The movement and proliferation of the cancer cells may be regulated in an autocrine or paracrine fashion by protein factors present in the peritoneal fluid. Although the effects of growth factors like epidermal growth factor (EGF), 1 basic fibroblast growth factor, transforming growth factor ␣, hepatocyte growth factor, and platelet-derived growth factor on ovarian cancer cell migration and growth have been characterized (1) (2) (3) , there is scant information on chemokine signaling mechanisms in this tumor type.
Chemokines have pleiotropic biological effects. They are well known to regulate the recruitment and trafficking of leukocytes to sites of inflammation. The ␣ chemokine interleukin-8 (IL-8) also has been reported to promote tumor cell growth (4, 5) . It can induce migration of melanoma and breast carcinoma cells (6, 7) and stimulate angiogenesis (8) . Despite the prominent migratory behavior of ovarian cancer, no report to our knowledge has investigated which chemokine receptors and/or ligands may be involved in this phenomenon.
Chemotactic and growth signals initiated by chemokines belonging to ␣ (-CXC), ␤ (-CC), ␥ (-C), and ␦ (-CX 3 C) subfamilies are all transduced by the activation of heptahelical G proteincoupled receptors (9) . The heterotrimeric GTP-binding proteins involved are members of the pertussis toxin-sensitive G i and -insensitive G q families. Both the G␣ subunits from the G q class and the G␤␥ subunit complex released from G i are involved in chemokine-induced signaling (10) . The activation of these G protein subunits by agonist-bound receptors triggers a typical signal transduction pathway involving activation of phospholipase C ␤ isoforms. This results in the generation of diacylglycerol and inositol 1,4,5-trisphosphate with a subsequent increase in protein kinase C (PKC) activity and intracellular Ca 2ϩ mobilization (10, 11) . In addition, although chemokine receptors lack tyrosine kinase activity, they can stimulate the phosphorylation of cytoskeletal proteins, p130 Cas and paxillin (12) , induce the activation of the related adhesion focal tyrosine kinase (also known as Pyk2 or CAK␤; 13), mitogenactivated protein kinases (Erk1/2, p38, and c-Jun kinase; 11, 13), phosphatidylinositol 3-kinase (11) , and Janus kinase 2 (14) . p44/42 MAP kinases, also termed extracellular signal-regulated kinases (Erk1 and Erk2), are important mediators of growth and other signals from cell surface receptors to the nucleus (15, 16) . Because most of the G protein-coupled receptors (GPCR) can activate a variety of effector pathways via various G protein subunits, considerable heterogeneity exists in the signaling pathways leading to Erk1/2 phosphorylation and the subsequent activation of transcription factors (17) (18) (19) (20) (21) (22) . An important step in the Ras/MAP kinase pathway is the formation of a Shc-Grb2.son-of-sevenless (23) or Grb2.son-ofsevenless (24) complex. Recently, several reports have shown that following GPCR ligation by agonists like lysophosphatidic acid (LPA), bradykinin, angiotensin II, and UTP, the formation of this complex is mediated by EGF and platelet-derived growth factor receptor kinases (25) (26) (27) (28) (29) (30) as well as by cytoplasmic Pyk2/related adhesion focal tyrosine kinase and Src family kinases (31) (32) (33) (34) . However, no information on whether chemokines utilize similar mechanisms of cross-talk has been presented.
With this background, we examined ovarian cancer cells and found robust expression of the IL-8-specific receptors CXCR-1 and CXCR-2. Stimulation of these cells with recombinant human IL-8 resulted in the rapid activation of p44/42 MAP kinases (Erk1/2). Furthermore, we found that the EGF receptor and c-Src participated in the transduction of GPCR-mediated IL-8 signals, indicating a newly observed link between G protein-coupled chemokine receptor activation and tyrosine kinases believed important in ovarian cancer cell proliferation.
EXPERIMENTAL PROCEDURES

Chemicals and Reagents Were Obtained from the Following
Sources-McCoy's 5A medium, fetal bovine serum (FBS), L-glutamine, and penicillin-streptomycin were from Life Technologies Inc.; protease inhibitors (phenylmethylsulfonyl fluoride, aprotinin, trypsin inhibitor, leupeptin), phorbol 12-myristate 13-acetate (PMA), and pertussis toxin (PTX) were from Sigma; genestein, herbimycin A, tyrphostin AG1478, Src family tyrosine kinase inhibitor PP1, and the calcium ionophore A23187 were from Calbiochem; myelin basic protein (MBP) was from Upstate Biotechnology (Lake Placid, NY); recombinant human IL-8, tumor necrosis factor (TNF-␣), and EGF were from R & D Systems (Minneapolis, MN); glutathione S-transferase (GST) amino acid residues 1-218, full-length GST⅐Grb2 (amino acids 1-217) fusion protein, GST, normal rabbit and mouse IgG and mouse IgG conjugated with fluorescein isothiocyanate were all procured from Santa Cruz Biotechnology (Santa Cruz, CA). The Dc protein assay kit and nitrocellulose transfer membrane were from Bio-Rad, and the enhanced chemiluminescence (ECL) detection system, donkey anti-rabbit and sheep antimouse IgG conjugated to horseradish peroxidase, protein A and Gamma Bind plus Sepharose and Glutathione-Sepharose 4B were from Amersham Pharmacia Biotech.
Antibodies and Their Specificities-Mouse monoclonal antibody to human interleukin-8 receptor A (IL-8RA or CXCR-1) conjugated with phycoerythrin (PE) and PE-mouse IgG2b isotype control were from PharMingen (San Diego, CA), and monoclonal anti-IL-8RB (CXCR-2) was a gift from LeukoSite, Inc. (Cambridge, MA). Monoclonal antibody from Santa Cruz (sc-120, 528) raised against the cell surface epitope of the human EGF receptor (EGFR) was used for immunoprecipitations, and rabbit anti-EGFR (sc-03, 1005) with an epitope mapping at residues 1005-1016 of the precursor form of EGFR (human origin) was used for Western blotting. Rabbit polyclonal antibodies to Erk1 (sc-93, C-16) and Erk2 (sc-154, C-14) with epitopes corresponding to an amino acid sequence mapping at the carboxyl terminus of Erk1-encoded MAP kinase p44 and Erk2-encoded MAP kinase p42 of rat origin were used in the in vitro kinase assays. Rabbit polyclonal antibodies to human Shc (06 -203; Upstate Biotechnology) corresponding to amino acids 366 -473 and monoclonal anti-Shc antibody (sc-967) corresponding to amino acids 366 -473 within the SH2 domain of Shc (human origin) were used for immunoprecipitation and Western blotting, respectively. For antiphosphotyrosine Western blot analysis, a combination of PY99 (sc-7020, dilution 1:1000) and 4G10 (a gift from Dr. B. Druker, Oregon Health Sciences University, Portland, OR; dilution 1:3000) was used.
Cells, Culture Conditions, and Stimulation-SK-OV-3 cells (ATCC, TB-77), derived from the malignant ascites of a human ovary adenocarcinoma, were maintained in McCoy's 5A medium supplemented with 10% FBS, 1.5 mM L-glutamine, and 20 IU/ml penicillin-streptomycin at 37°C in humidified 5% CO 2 atmosphere. Prior to stimulation, the cells were serum-starved for 24 h. Stimulation occurred at 37°C with IL-8 (100 ng/ml) or EGF (10 ng/ml) as specified in the figures.
Flow Cytometric Analysis-Cells were detached from the substratum with 2 mM EDTA/Dulbecco's PBS (minus Ca 2ϩ and Mg 2ϩ ). They were washed twice with D-PBS and resuspended at 3 ϫ 10 5 cells/0.5 ml and then incubated on ice for 30 min with primary antibody (anti-human IL-8RA-conjugated with PE or with PE-conjugated mouse IgG2b isotype control). Cells were screened for the expression of IL-8RB by incubation on ice for 30 min with monoclonal IL-8RB primary antibody, washed, and then incubated for another 30 min on ice with the secondary antibody (goat anti-mouse IgG labeled with fluorescein isothiocyanate). Normal mouse IgG was used as the control. After the final incubation, cells were washed twice with D-PBS and analyzed immediately on a Becton Dickinson FACSCAN driven by Cell Quest software (Beth Israel Deaconess Medical Center, Boston, MA).
Chemokine Secretion-Cells (4 ϫ 10 5 ) plated in 12-well plates were allowed to grow to 80% confluency and then were serum-starved for 24 h. Quiescent cells were then incubated for 6 h in serum-free medium or medium containing fetal bovine serum or TNF-␣. Culture medium was cleared by centrifugation at 2000 rpm and 4°C to remove debris. IL-8 secreted into the culture medium was quantitated using the human IL-8 enzyme-linked immunosorbent assay kit obtained from Endogen (Woburn, MA).
Time-lapse Video Microscopy-The effect of IL-8 on the morphology of SK-OV-3 cells was monitored using time-lapse video microscopy. Cells were detached from the substratum with 2 mM EDTA/D-PBS (minus Ca 2ϩ and Mg 2ϩ ), and washed twice with McCoy's 5A medium. Before the start of the experiment, cells (1 ϫ 10 5 ) were cultured in 35 ϫ 10 mm tissue culture plates (Becton Dickinson Labware) in serum-free McCoy's 5A medium for 18 h in a humidified 37°C incubator with 5% CO 2 . The cells were then observed via time-lapse video microscopy in a 37°C and 5% CO 2 controlled chamber, and 12 h later they were stimulated with IL-8 (50 ng/ml). Changes in cell morphology were examined using an Olympus IX70 inverted microscope, Omega temperature control device, Optronics Engineering DE1-750 3CCD digital video camera, and Sony SVT-S3100 time-lapse S-VHS video recorder. For image presentation, video images were captured and printed with the Sony Color Video Printer UP-5600MD.
Immunoprecipitation and Immunoblotting-After stimulation, monolayers were washed with ice-cold D-PBS and lysed in chilled radioimmune precipitation buffer (50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 1% Nonidet P-40, 1 mM Na 3 VO 4 , 1 mM NaF, 1 mM sodium pyrophosphate, 1 mM phenylmethylsulfonyl fluoride, 1 g/ml aprotinin, 1 g/ml leupeptin, 1 g/ml trypsin inhibitor, 1 g/ml pepstatin). Cell lysates were cleared by centrifugation at 13,000 rpm, and protein concentration was determined using a Dc protein assay kit (Bio-Rad). For immunoprecipitations, 1 ml of cell lysates (0.5 to 1.0 mg/ml protein) was incubated at 4°C for 1-2 h with the appropriate primary antibodies. The immune complexes absorbed to protein A or Gamma Bind plus Sepharose were washed thrice with chilled lysis buffer, once with D-PBS, and then eluted with 2ϫ Laemmli SDS sample buffer. When GST fusion proteins were used in immunoprecipitations, glutathione-Sepharose 4B was employed to adsorb the immune complexes. The immunoprecipitated proteins were resolved by SDS-polyacrylamide gel electrophoresis and transferred onto nitrocellulose membranes (Bio-Rad). The membranes were blocked for 1 h at room temperature in 5% milk prepared in Tris-buffered saline-T (10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% Tween 20) and probed for 1-2 h at room temperature or overnight at 4°C with the appropriate antibodies diluted in blocking buffer. The membranes were washed and incubated with the appropriate horseradish peroxidase-conjugated secondary antibody diluted in Tris-buffered saline-T for 1 h at room temperature. The immune complexes on the washed membranes were visualized using ECL reagents.
In Vitro Kinase Assay-MAP kinase activity was determined following immunoprecipitation using MBP as substrate. Serum-starved cells pretreated with vehicle or specific inhibitors were stimulated with IL-8 or EGF, as indicated in the figures. Cells were lysed in lysis buffer and clarified at 15,000 ϫ g for 15 min, and then 100 -500 g of protein was immunoprecipitated with 1 g each of anti-Erk1 and Erk2. After 4 h at 4°C, the immune complexes were absorbed to protein A-Sepharose. After overnight rocking at 4°C, the beads were washed thrice with lysis buffer containing protease inhibitors and twice with kinase buffer (20 mM Hepes, pH 7.4, 10 mM MgCl 2 , 3 mM ␤-mercaptoethanol). Phosphorylation of MBP was carried out at room temperature for 30 min in a total volume of 25 l by the addition of a mixture containing 5-7 g of MBP, 5 Ci of [␥-
32 P]ATP, and 20 M ATP to the Erk1/2 immunoprecipitates. The reaction was terminated by the addition of 4ϫ Laemmli SDS buffer.
32 P-labeled MBP was resolved on 14% SDS-polyacrylamide gel electrophoresis. 
RESULTS
Cell Surface Expression of CXCR-1 and CXCR-2 Receptors-
IL-8 Activates Erk1/2 via the EGF Receptor
human IL-8RA (CXCR-1) antibody conjugated with PE or anti-IL-8RB (CXCR-2) primary antibody followed by staining with fluorescein isothiocyanate-labeled secondary antibody displayed a shift in fluorescence intensity (Fig. 1) . This confirmed the expression of ␣ chemokine IL-8-specific receptors, CXCR-1 and CXCR-2.
Secretion of IL-8 Protein-Secretion of IL-8 protein by various cell lines in the absence or presence of cytokines like TNF-␣, IL-1␣, and -␤ has been reported (4, 35, 36) . To determine if SK-OV-3 cells produced IL-8 protein, monolayers of quiescent cells were stimulated for 6 h with medium alone or medium containing varying concentrations of FBS or TNF-␣ (20 ng/ml). A dose-dependent increase in the release of IL-8 was detected in response to FBS by enzyme-linked immunosorbent assay. At 5% FBS, approximately 1 ng/ml of IL-8 was detected; controls without serum yielded 0.1 ng/ml, and TNF-␣ stimulation yielded 1.2 ng/ml (data not shown).
IL-8 Induces Morphological Changes in SK-OV-3 Cells-
Chemotactically stimulated myeloid cells, neutrophils, and breast cancer carcinoma cell lines undergo transient cytoskeletal rearrangements that lead to morphological alterations, ultimately resulting in cell migration (7, 37, 38) . Similarly, SK-OV-3 cells, as shown in Fig. 2 , E-H, displayed increased membrane ruffling and altered membrane protrusions in response to IL-8 as determined by time-lapse video microscopy. As seen in Fig. 2 , A-D, untreated SK-OV-3 cells had little membrane ruffling and minimal actin protrusions. When IL-8 was added to the cells, increased membrane ruffling and the formation/retraction of thin actin-like projections were readily apparent (Fig. 2, E-H (15, 18, 39) . To examine the effect of IL-8 on MAP kinase activation, lysates from SK-OV-3 cells treated with IL-8 (100 ng/ml) were immunoprecipitated with anti-Erk1 and Erk2-specific antibodies and subjected to an in vitro kinase assay. The activation of these MAP kinases was assessed by the extent of phosphorylation of the substrate, MBP. Maximum activation was observed between 1 and 2 min, and leveled off by 10 min (Fig. 3A) .
Depending on the G protein subunits involved, a variety of effectors can be activated that result in multiple signaling pathways. We therefore mapped pathways leading to Erk1/2 activation in SK-OV-3 cells in response to IL-8 stimulation. Pretreatment of cells with PTX (100 ng/ml) or tyrosine kinasespecific inhibitors genestein (20 M) and herbimycin A (1 M) or down-regulation of PKC by prolonged exposure to phorbol 12-myristate 13-acetate (100 nM) each had a significant effect on reducing enzyme activity (Fig. 3B) . This suggested the involvement of tyrosine kinases in CXCR-1 and CXCR-2 mediated signaling in these cells.
IL-8 Induces Association of the Phosphorylated EGF Receptor with Shc and Grb2-Activation of the Ras-dependent MAP kinase signaling pathway by receptor tyrosine kinases involves the recruitment of a Grb2.son-of-sevenless complex to the plasma membrane, either directly or indirectly by its association with phosphorylated Shc (24, 25, 34, 40, 41) . To address whether these cytosolic adaptor molecules participated in the transduction of IL-8 signals, interacting proteins from cell lysates treated with IL-8 (100 ng/ml) or EGF (10 ng/ml) were immunoprecipitated with a full-length GST⅐Grb2 fusion protein. IL-8 treatment induced phosphorylation of a number of cellular proteins and their association with GST-Grb2 (Fig. 4) . Of these Grb2-associating proteins, the ϳ170-kDa molecule was identified as the EGF receptor and the 46-, 52-, and 66-kDa proteins as the isoforms of Shc. Although the phosphorylation and association of the 46 and 52 kDa forms of Shc were transient, occurring as early as 1 min, the phosphorylation of p66 was much weaker and sustained over a 30-min period.
Inhibition of EGF Receptor Autophosphorylation Blocks CXCR-1/2-mediated Mitogen-activated Protein Kinase Activation-The EGF receptor is one of the protein-tyrosine kinases that has been implicated in transducing signals initiated by GPCR-specific agonists like angiotensin II, LPA, and bombesin (25) (26) (27) . To determine if the EGF receptor plays a role in CXCR-1/2-mediated signaling in ovarian cancer cells, lysates from cells stimulated with IL-8 (100 ng/ml) or EGF (10 ng/ml) were immunoprecipitated with a monoclonal anti-EGFR antibody. Western blot analysis of the immunoprecipitated proteins clearly showed the phosphorylation of a 170-kDa protein.
Transactivation of the EGFR was rapid, reaching a maximum by 2 min (Fig. 5) . The specificity of this rapid phosphorylation was further confirmed by pretreating cells with the EGF receptor kinase-specific inhibitor, tyrphostin AG1478. Incubation of cells with AG1478 (250 nM) for 30 min prior to stimulation with IL-8 or EGF significantly reduced the activation of the EGF receptor (Fig. 5) .
Tyrphostin AG1478, the inhibitor of EGF receptor autophosphorylation, was found to partially block IL-8 or EGF-induced downstream signals leading to the activation of MAP kinase (Fig. 6, A and B, and 9A ). In the control cells, the maximum phosphorylation of the MBP substrate occurred at 1 min and tapered off by 10 min, whereas in the AG1478-treated cells there was a weak but gradual increase in phosphorylation, peaking by 10 min.
IL-8 Induces Calcium-dependent Phosphorylation of the EGF Receptor-CXCR-1 and CXCR-2 stimulation activate the phos-
phatidylinositol-phospholipase C pathway leading to increases in intracellular calcium levels (10, 42) . We assessed the role of Ca 2ϩ in the IL-8-induced transactivation of the EGF receptor by treating the cells with the calcium ionophore, A23187 (10 M). A rapid increase in the tyrosyl phosphorylation of the EGF receptor kinase was observed (Fig. 7) . The intracellular calcium chelator 1,2-bis(o-aminophenoxy) ethane-N,N,NЈ,NЈ-tetraacetic acid tetra (acetoxymethyl) ester (10 M) blocked this phosphorylation, whereas the extracellular calcium chelator EGTA (5 mM) had no effect on the extent of phosphorylation (data not shown). This indicated that the transactivation of the receptor tyrosine kinase was mediated by intracellular calcium mobilization. 
Role of c-Src Kinase in IL-8-induced EGFR Phosphorylation and MAP Kinase
IL-8 Activates Erk1/2 via the EGF Receptor
ticipate by phosphorylating two important substrates, Shc and EGFR (26, 34, 43, 44) . We therefore treated cells with the Src kinase family inhibitor, PP1, prior to exposure to IL-8. We did not observe changes in the phosphorylation of EGFR in response to IL-8 under these conditions (Fig. 8) . This result suggests another nonreceptor kinase may contribute to the transactivation of EGFR upon IL-8 stimulation in SK-OV-3 cells. PP1 did, however, have an inhibitory effect on the phosphorylation of Shc protein (Fig. 9A) and on the activation of Erk1/2 in response to both IL-8 and EGF (Fig. 9B) . We observed robust expression of the CXCR-1 and CXCR-2 receptors on SK-OV-3 human ovarian cancer cells (Fig. 1) . We also detected significant amounts of extracellular IL-8 protein in the culture medium. IL-8, a potent neutrophil chemoattractant, is known to induce migratory responses in non-hematopoietic cells such as human A2058 melanoma and MCF-7 and ZR-75-1 breast cancer cells (7) . The mechanisms by which cells translocate in response to various factors are complex. The migratorial processes include dissolution of cell surface contacts, formation of lamellipodia, actin filament fragmentation and nucleation, and finally contraction of the actin filament network leading to cell movement (51) . In the present study, exposure to IL-8 caused changes in the shape of the ovarian cancer cells with increased membrane ruffling and the formation/retraction of thin actin-like projections. This would indicate that IL-8 potentially may be involved in the cell motility of ovarian cancer cells and could contribute to the process of metastasis.
Erks are important mediators of signals from cell surface receptors to the nucleus (16, 20) . Agonists like hormones, neuropeptides, and chemokines that activate heterotrimeric G proteins signal to these MAP kinases (15) . It has been reported that the IL-8-specific receptors CXCR-1 and CXCR-2, in neutrophils, COS and Jurkat cells, couple to both PTX-sensitive G i and -insensitive G q (␣14 and ␣16) family members and stimulate phosphatidylinositol hydrolysis with increases in intracellular calcium levels and PKC activity (10, 42, 52) . PKC is known to mediate activation of MAP kinase both via Ras-dependent and -independent mechanisms (20, 53, 54) . In SK-OV-3 cells, IL-8 induced activation of p44/42 MAP (Erk1/2) kinases (Fig. 3A) . This effect was significantly reduced when cells were treated with PTX or after cellular depletion of PKC by prolonged exposure to phorbol 12-myristate 13-acetate (Fig.  3B) . Several studies suggest that the potent mitogenic effects of GPCR-specific agonists (angiotensin II, LPA, and bombesin) in different cell types result from cooperative activation of multiple signal-transducing pathways involving G proteins and tyrosine kinases (26, 27, 30, 32, 34, 55, 56) . This, to our knowledge, has not yet been investigated with chemokines. In SK-OV-3 cells, MAP kinase activity was attenuated when cells were pretreated with the tyrphostins genestein and herbimycin A prior to IL-8 stimulation (Fig. 3B) . This clearly showed the involvement of tyrosine kinases in IL-8 signal transduction.
An important feature in tyrosine kinase receptor-mediated activation of Ras-dependent MAP kinase activation is the phosphorylation of the receptor and its association with Grb2 either directly (24) or indirectly through the phosphorylated Shc adaptor protein (23, 41, 57, 58) . There is also the recruitment of the Ras guanine nucleotide exchange factor to the plasma membrane where it activates Ras, thereby initiating a signaling cascade leading to the activation of MAP kinase. Several studies have demonstrated the involvement of EGFR in mitogenic signaling induced by GPCR agonists (25) (26) (27) (28) (29) 43) . In the present study, we observed the phosphorylation of several cellular proteins upon IL-8 stimulation. Of these Grb2-associating proteins, 46-, 52-, and 66-kDa proteins were identified as isoforms of the Shc protein, and the high molecular mass (ϳ170 Immune complexes were analyzed for MAP kinase activity by in vitro kinase assay as described under "Experimental Procedures." kDa) protein was identified as EGFR (Fig. 4) . It is possible that other members of the EGFR family like ErbB2 and ErbB3 are present in the Grb2 fusion protein complex. Using the specific inhibitor AG1478, we showed that the intrinsic kinase activity of EGFR was required for receptor autophosphorylation (Fig. 5 ) and for phosphorylation of downstream molecules like Shc (Fig.  6A and 9A ), leading to MAP kinase activation (Fig. 6B) . Intrinsic EGFR kinase activity was also required for Shc phosphorylation in studies of LPA, endothelin-1, and ␣-thrombin-induced signaling in Rat-1 cells, UTP signaling in PC12 neuronal cells, and angiotensin II-induced responses in vascular smooth muscle cells (25) (26) (27) (28) .
Previously reported GPCR agonists that are involved in EGFR transactivation act via the G i and G q class of G proteins (25, 26, 28, 43) . The ␣ subunit of the G q family member and ␤␥ released from G i activate various isoforms of phospholipase C-␤, thereby increasing intracellular Ca 2ϩ levels (59 -61) . In PC12 neuronal cells, membrane depolarization induced Ca 2ϩ influx and treatment with bradykinin or calcium ionophore also triggered EGFR transactivation (29) . Tyrosyl phosphorylation of the EGF receptor in SK-OV-3 cells (Fig. 7) was also initiated by the calcium ionophore A23187, which mimicks the G protein-mediated increase in Ca 2ϩ flux. The intracellular calcium chelator 1,2-bis(o-aminophenoxy) ethane-N,N,NЈ,NЈ-tetraacetic acid tetra (acetoxymethyl) ester blocked this phosphorylation, although no such effect was observed when the influx of extracellular Ca 2ϩ was blocked by EGTA (data not shown). We found that intracellular Ca 2ϩ was both necessary and sufficient to trigger EGFR transactivation in a ligandindependent manner in ovarian cancer cells. It is possible that the Ca 2ϩ -dependent transactivation of the EGF receptor in SK-OV-3 cells may result from the activation of a nonreceptor kinase, the involvement of phosphatidylinositol-phospholipase C-mediated activation of Ca 2ϩ -dependent PKC isoforms, or the inhibition of a phosphotyrosine phosphatase. These possibilities will be addressed in future studies.
The Src family of protein-tyrosine kinases has been implicated in relaying responses of various mitogenic factors (56, 62, 63) . However, there are conflicting reports on its role in GPCRmediated signaling. Roche et al. (64) and Kranenburg et al. (65) reported that c-Src activity was not required for relaying the mitogenic effects of LPA, bombesin, and thrombin. Activation of p60 c-src was required for the G i -coupled LPA receptor-mediated G␤␥ subunit-dependent activation of Erk1/2 in COS-7 cells (26, 34) and for the G i and G q/11 -coupled (LPA, bradykinin, and thrombin) receptor stimulation of Erk1/2 in PC12 cells and growth-responsive fibroblasts (25, 30) . Activated Src mediates Ras/MAP kinase activation through tyrosine phosphorylation of the adaptor protein Shc and its subsequent association and complex formation with Grb2 as demonstrated for the receptors for N-formyl peptides, LPA, UTP, angiotensin II, and the ␣2A adrenergic receptors (26 -28, 43, 44) . Another prominent substrate of Src is EGFR (63, 66) . Using the specific inhibitor PP1, we showed that Src phosphorylated Shc protein and was required for MAP kinase activity (Fig. 9, A and B) but not for EGFR phosphorylation upon IL-8 stimulation in SK-OV-3 cells (Fig. 8) . Similar results were reported by Daub et al. (26) on the effects of LPA in COS cells. Thus, additional signaling factors like tyrosine kinases may act downstream of EGFR in SK-OV-3 cells.
In these ovarian cancer cells, CXCR-1/2 receptors mediated the activation of p44/42 MAP kinase via multiple tyrosine kinase pathways (Fig. 3B) . The increase in intracellular Ca 2ϩ appeared responsible for the transactivation of the EGF receptor tyrosine kinase (Fig. 7) . It is known that both the G␤␥ subunit and the G␣ subunit of the G q class of proteins contribute to increases in intracellular Ca 2ϩ levels in response to IL-8 (10, 42, 52) . Whereas MAP kinase activity was totally abolished by PTX, the extent of EGFR phosphorylation was unaffected (data not shown). These results suggest that a member of a PTX-insensitive G q family regulates MAP kinase activity via an EGF receptor tyrosine kinase pathway in SK-OV-3 cells. The involvement of EGFR in the signaling of CXCR-1/2 suggests important cross-talk between chemokine and growth factor receptor signaling pathways in ovarian cancer.
